Rockeby Biomed Ltd Company Profile - RBY AUSTRALIA Market Size, Market Share and Demand Forecast

Rockeby Biomed Ltd - Company Profile Snapshot

Supplementary Analyses Reports

Financial Statement Analysis

Financial Ratio Analysis

WRIGHT QUALITY ANALYSIS ... and more!

View sample Supplementary Analyses (PDF)

Company Profile:	Rockeby Biomed Ltd
Ticker:	RBY
Exchanges:	SYD
2009 Sales:	908,780
Major Industry:	Miscellaneous
Sub Industry:	Medical Services
Country:	AUSTRALIA
Employees:	15000

Business Description
Rockeby Biomed Ltd. The Group's principal activities are researching, developing and marketing rapid testing technologies for infectious disease in humans and animals and lifestyle health products including CanDia5 and Avian Influenza Virus test kits. It operates in Australia, Asia Pacific, Europe, Middle East and Africa.

Not the Report you are looking for?
Click here for more browsing options.

The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
- Address (mailing), Phone Number, Web Address - Earnings/Dividends - Employees - Exchanges Listed - Financial Ratio Analysis	- Recent Stock Performance - Sales (recent year) - Senior Officers - Shareholder Information - Stock Analysis Summary

add Premium Analyses Reports:
Purchase Reports:			(Combined total)
ALL Basic Reports on this Company	$39.95	+ Analyses Reports	$54.95
Single Company Profile Report	$24.95
or SUBSCRIBE for full access** to over 180,000 company reports:
Monthly Basic Subscription	$59.99	+ Analyses Reports	$74.99
Annual Basic Subscription	$600/yr	+ Analyses Reports	$750/yr

* If a currency is not selected, the report will be delivered in the local currency of the company
** Full access limits users to 500 reports per month

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report